Form 4: Inspire Medical Systems CFO Reports Stock Transactions

Richard Buchholz, CFO of Inspire Medical Systems, reports the acquisition and disposal of company stock, including tax withholding and an award of restricted stock units.

Summary

• Richard Buchholz, the Chief Financial Officer of Inspire Medical Systems, reported changes in his beneficial ownership of the company's stock.
• On February 9, 2025, 314 shares of common stock were disposed of at a price of $182.15 per share.
• This disposition was likely for tax withholding purposes.
• On February 13, 2025, Mr. Buchholz acquired 5,076 shares of common stock through a restricted stock unit (RSU) award.
• These RSUs vest in three equal annual installments starting on February 13, 2026.
• Following these transactions, Mr. Buchholz directly owns 32,674 shares of Inspire Medical Systems stock.
• He also has indirect ownership of 1,350 shares each held by his daughter and three sons.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing showing stock transactions. The RSU grant is a positive sign of aligning management with shareholder interests, but the tax withholding is a neutral event.

Positives

• The grant of 5,076 restricted stock units to the CFO aligns his interests with the long-term performance of the company.
• The vesting schedule encourages continued employment with the company.

Future Outlook

The restricted stock units vest in three equal annual installments commencing on February 13, 2026, contingent on the Reporting Person's continuous employment with the Issuer.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of company insiders. This filing indicates the CFO's ongoing investment in the company through stock ownership.

Comparison to Industry Standards

• Stock grants to executives are a common practice in the medical device industry to incentivize performance and align management's interests with shareholders.
• Vesting schedules, like the three-year annual vesting in this case, are standard for RSU awards.
• Comparing the size of the RSU award to those of CFOs at comparable medical device companies (e.g., Medtronic, Stryker, Boston Scientific) would provide context on its relative significance.

Stakeholder Impact

• The RSU grant could positively impact shareholder confidence by aligning management's interests with the company's long-term success.

Key Dates

Keywords

Inspire Medical Systems, INSP, Richard Buchholz, CFO, Form 4, Stock, Restricted Stock Units, RSU, Beneficial Ownership, Insider Trading